[{"address1": "2051 Ringwood Avenue", "city": "San Jose", "state": "CA", "zip": "95131", "country": "United States", "phone": "408 457 3700", "website": "https://www.ranitherapeutics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-102, a parathyroid hormone that is in Phase I clinical trial for the treatment of osteoporosis; RT-105, an anti-TNF-alpha antibody that is in preclinical studies to treat psoriatic arthritis; RT-110, a parathyroid hormone for the treatment of hypoparathyroidism; and RT-111, an ustekinumab biosimilar for the treatment of various inflammatory conditions. Rani Therapeutics Holdings, Inc. was founded in 2012 and is headquartered in San Jose, California.", "fullTimeEmployees": 140, "companyOfficers": [{"maxAge": 1, "name": "Mr. Talat  Imran", "age": 41, "title": "CEO & Director", "yearBorn": 1982, "fiscalYear": 2022, "totalPay": 827000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Svai S. Sanford", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 661600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mir  Hashim", "age": 63, "title": "Chief Scientific Officer", "yearBorn": 1960, "fiscalYear": 2022, "totalPay": 661600, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eric  Groen", "age": 52, "title": "General Counsel", "yearBorn": 1971, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Bella  Vazquez", "title": "Vice President of Human Resources", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kate  McKinley M.B.A.", "title": "Chief Business Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Arvinder  Dhalla", "title": "Vice President of Clinical Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 6.87, "open": 7.6, "dayLow": 7.06, "dayHigh": 8.75, "regularMarketPreviousClose": 6.87, "regularMarketOpen": 7.6, "regularMarketDayLow": 7.06, "regularMarketDayHigh": 8.75, "beta": 0.916, "forwardPE": -11.893939, "volume": 1397733, "regularMarketVolume": 1397733, "averageVolume": 115414, "averageVolume10days": 315210, "averageDailyVolume10Day": 315210, "bid": 7.72, "ask": 8.45, "bidSize": 100, "askSize": 100, "marketCap": 406316768, "fiftyTwoWeekLow": 1.82, "fiftyTwoWeekHigh": 8.75, "fiftyDayAverage": 3.7426, "twoHundredDayAverage": 3.276975, "currency": "USD", "enterpriseValue": 198557664, "floatShares": 13441244, "sharesOutstanding": 26298600, "sharesShort": 1920035, "sharesShortPriorMonth": 1714414, "sharesShortPreviousMonthDate": 1709164800, "dateShortInterest": 1711584000, "sharesPercentSharesOut": 0.073699996, "heldPercentInsiders": 0.48416, "heldPercentInstitutions": 0.1337, "shortRatio": 22.33, "shortPercentOfFloat": 0.14140001, "impliedSharesOutstanding": 51760100, "bookValue": 0.494, "priceToBook": 15.890689, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -33970000, "trailingEps": -1.33, "forwardEps": -0.66, "pegRatio": 0.58, "enterpriseToEbitda": -3.042, "52WeekChange": 0.48674238, "SandP52WeekChange": 0.2160933, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "RANI", "underlyingSymbol": "RANI", "shortName": "Rani Therapeutics Holdings, Inc", "longName": "Rani Therapeutics Holdings, Inc.", "firstTradeDateEpochUtc": 1627651800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "5ed5bf18-2fc9-357f-8d44-03f1c0fe19bf", "messageBoardId": "finmb_242425883", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.85, "targetHighPrice": 12.0, "targetLowPrice": 4.0, "targetMeanPrice": 8.86, "targetMedianPrice": 9.0, "recommendationMean": 1.6, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 48539000, "totalCashPerShare": 1.864, "ebitda": -65277000, "totalDebt": 30099000, "quickRatio": 6.101, "currentRatio": 6.365, "debtToEquity": 118.3, "returnOnAssets": -0.4979, "returnOnEquity": -1.3652099, "freeCashflow": -26958000, "operatingCashflow": -51236000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-04-18"}]